Chikungunya Vaccine Deemed Immunogenic and Safe

August 15, 2014 5:08 PM

14 0

FRIDAY, Aug. 15, 2014 (HealthDay News) -- A chikungunya virus-like particle (VLP) vaccine is immunogenic and seems safe, according to a study published online Aug. 15 in The Lancet.

Lee-Jah Chang, M.D., from the National Institutes of Health in Bethesda, Md., and colleagues examined the safety, tolerability, and immunogenicity of a new candidate vaccine for chikungunya virus in a phase 1, dose-escalation trial involving healthy adults aged 18 to 50 years. Twenty-five participan...

Read more

To category page